Tooba Jabri

560 total citations
23 papers, 434 citations indexed

About

Tooba Jabri is a scholar working on Pharmaceutical Science, Biomaterials and Materials Chemistry. According to data from OpenAlex, Tooba Jabri has authored 23 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmaceutical Science, 7 papers in Biomaterials and 5 papers in Materials Chemistry. Recurrent topics in Tooba Jabri's work include Advanced Drug Delivery Systems (7 papers), Nanoparticle-Based Drug Delivery (5 papers) and Nanoparticles: synthesis and applications (5 papers). Tooba Jabri is often cited by papers focused on Advanced Drug Delivery Systems (7 papers), Nanoparticle-Based Drug Delivery (5 papers) and Nanoparticles: synthesis and applications (5 papers). Tooba Jabri collaborates with scholars based in Pakistan, United Arab Emirates and Türkiye. Tooba Jabri's co-authors include Muhammad Raza Shah, Komal Rao, Muhammad Ali Imran, Samina Perveen, Imdad Ali, Shafiullah, Talat Roome, Muhammad Kawish, Shakil Ahmed and Kanwal Iqbal and has published in prestigious journals such as SHILAP Revista de lepidopterología, Carbohydrate Polymers and RSC Advances.

In The Last Decade

Tooba Jabri

22 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tooba Jabri Pakistan 11 119 106 103 98 54 23 434
Komal Rao Pakistan 12 91 0.8× 128 1.2× 135 1.3× 79 0.8× 52 1.0× 20 467
Sorina Nicoleta Voicu Romania 12 95 0.8× 107 1.0× 100 1.0× 77 0.8× 39 0.7× 31 510
Bennett C. Nwanguma Nigeria 9 146 1.2× 173 1.6× 75 0.7× 137 1.4× 34 0.6× 30 613
Hock Ing Chiu Malaysia 8 123 1.0× 70 0.7× 88 0.9× 84 0.9× 45 0.8× 12 352
Salar Khaledian Iran 15 159 1.3× 89 0.8× 181 1.8× 171 1.7× 27 0.5× 23 489
Ashish Wadhwani India 11 192 1.6× 114 1.1× 58 0.6× 89 0.9× 74 1.4× 23 602
Anna Świderska‐Środa Poland 13 145 1.2× 83 0.8× 123 1.2× 153 1.6× 36 0.7× 25 499
Shadrach Chinecherem Eze Nigeria 4 142 1.2× 119 1.1× 60 0.6× 127 1.3× 33 0.6× 18 477
Emmanuel Chekwube Ossai Nigeria 7 150 1.3× 144 1.4× 66 0.6× 165 1.7× 36 0.7× 16 528
Khaled AbouAitah Egypt 15 206 1.7× 124 1.2× 159 1.5× 213 2.2× 53 1.0× 25 655

Countries citing papers authored by Tooba Jabri

Since Specialization
Citations

This map shows the geographic impact of Tooba Jabri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tooba Jabri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tooba Jabri more than expected).

Fields of papers citing papers by Tooba Jabri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tooba Jabri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tooba Jabri. The network helps show where Tooba Jabri may publish in the future.

Co-authorship network of co-authors of Tooba Jabri

This figure shows the co-authorship network connecting the top 25 collaborators of Tooba Jabri. A scholar is included among the top collaborators of Tooba Jabri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tooba Jabri. Tooba Jabri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jabri, Tooba, et al.. (2025). Liposome-based ethyl 3,4,5-trihydroxybenzoate nanoformulation mitigates apoptosis and inflammation associated with acute renal injury. Journal of Drug Delivery Science and Technology. 112. 107253–107253. 1 indexed citations
4.
Jabri, Tooba, et al.. (2024). Lecithin Derived Nano-Propyl Gallate as Non-Toxic Anti-Inflammatory Agent: Synthesis, In-Vitro and In-Vivo Investigations. Journal of Cluster Science. 35(6). 2007–2017. 2 indexed citations
5.
Siddiqui, Ruqaiyyah, Muhammad Kawish, Tooba Jabri, et al.. (2023). Nanocarrier Drug Conjugates Exhibit Potent Anti-Naegleria fowleri and Anti-Balamuthia mandrillaris Properties. SHILAP Revista de lepidopterología. 11(2). 58–58. 1 indexed citations
6.
Akbar, Noor, Muhammad Kawish, Tooba Jabri, et al.. (2023). Cinnamic acid and lactobionic acid based nanoformulations as a potential antiamoebic therapeutics. Experimental Parasitology. 246. 108474–108474. 5 indexed citations
7.
Jabri, Tooba, et al.. (2023). Antibacterial Properties of Ethacridine Lactate and Sulfmethoxazole Loaded Functionalized Graphene Oxide Nanocomposites. Antibiotics. 12(4). 755–755. 9 indexed citations
8.
Siddiqui, Ruqaiyyah, et al.. (2023). Anti-Balamuthia mandrillaris and anti-Naegleria fowleri effects of drugs conjugated with various nanostructures. Archives of Microbiology. 205(5). 170–170. 4 indexed citations
9.
Jabri, Tooba, Tasmina Kanwal, Samina Perveen, et al.. (2023). Improving curcumin bactericidal potential against multi-drug resistant bacteria via its loading in polydopamine coated zinc-based metal–organic frameworks. Drug Delivery. 30(1). 2159587–2159587. 33 indexed citations
10.
Jabri, Tooba, Talat Roome, Muhammad Ali Imran, et al.. (2022). Fabrication of hesperidin hybrid lecithin-folic acid silver nanoparticles and its evaluation as anti-arthritis formulation in autoimmune arthritic rat model. Journal of Molecular Structure. 1276. 134722–134722. 9 indexed citations
11.
Akbar, Noor, Muhammad Kawish, Tooba Jabri, et al.. (2022). Cinnamic Acid and Lactobionic Acid Based Nanoformulations as a Potential Antiamoebic Therapeutics. SSRN Electronic Journal. 1 indexed citations
12.
Siddiqui, Ruqaiyyah, Noor Akbar, Tooba Jabri, et al.. (2022). Zinc Oxide Nanoconjugates against Brain-Eating Amoebae. Antibiotics. 11(10). 1281–1281. 4 indexed citations
13.
Salam, Abdul, Tufail Hassan, Tooba Jabri, et al.. (2021). Electrospun Nanofiber-Based Viroblock/ZnO/PAN Hybrid Antiviral Nanocomposite for Personal Protective Applications. Nanomaterials. 11(9). 2208–2208. 36 indexed citations
14.
Ullah, Shafi, Imdad Ali, Komal Rao, et al.. (2021). Synthesis, characterization and drug delivery application of Dapsone based double tailed biocompatible nonionic surfactant. Chemistry and Physics of Lipids. 239. 105115–105115. 7 indexed citations
15.
Kawish, Muhammad, Tooba Jabri, Abdelbary Elhissi, et al.. (2021). Galactosylated iron oxide nanoparticles for enhancing oral bioavailability of ceftriaxone. Pharmaceutical Development and Technology. 26(3). 291–301. 11 indexed citations
16.
Akbar, Noor, Muhammad Kawish, Tooba Jabri, et al.. (2021). Enhancing efficacy of existing antibacterials against selected multiple drug resistant bacteria using cinnamic acid-coated magnetic iron oxide and mesoporous silica nanoparticles. Pathogens and Global Health. 116(7). 438–454. 12 indexed citations
17.
Kawish, Muhammad, Abdelbary Elhissi, Tooba Jabri, et al.. (2020). Enhancement in Oral Absorption of Ceftriaxone by Highly Functionalized Magnetic Iron Oxide Nanoparticles. Pharmaceutics. 12(6). 492–492. 18 indexed citations
19.
Jabri, Tooba, Muhammad Ali Imran, Shafiullah, et al.. (2018). Fabrication of lecithin-gum tragacanth muco-adhesive hybrid nano-carrier system for in-vivo performance of Amphotericin B. Carbohydrate Polymers. 194. 89–96. 29 indexed citations
20.
Rao, Komal, Muhammad Ali Imran, Tooba Jabri, et al.. (2017). Gum tragacanth stabilized green gold nanoparticles as cargos for Naringin loading: A morphological investigation through AFM. Carbohydrate Polymers. 174. 243–252. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026